Cargando…

Correction: Inflammatory Bowel Disease: How Effective Is TNF-α Suppression?

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5289480/ https://www.ncbi.nlm.nih.gov/pubmed/28152078 http://dx.doi.org/10.1371/journal.pone.0170865

Ejemplares similares

Inflammatory Bowel Disease: How Effective Is TNF-α Suppression?
por: Lo, Wing-Cheong, et al.
Publicado: (2016)

Anti-TNF-α Therapy Suppresses Proinflammatory Activities of Mucosal Neutrophils in Inflammatory Bowel Disease
por: Zhang, Cui, et al.
Publicado: (2018)

Correction: Cytomegalovirus Infection in Inflammatory Bowel Disease Is Not Associated with Worsening of Intestinal Inflammatory Activity
por: do Carmo, Alexandre Medeiros, et al.
Publicado: (2015)

Correction to: The Impact of Disease Activity on SD and ED in Patients With Inflammatory Bowel Disease
Publicado: (2022)

Correction to: Expert consensus on vaccination in patients with inflammatory bowel disease in Japan
por: Ishige, Takashi, et al.
Publicado: (2023)

Transmembrane TNF-α Density, but not Soluble TNF-α Level, is Associated with Primary Response to Infliximab in Inflammatory Bowel Disease
por: Amini Kadijani, Azade, et al.
Publicado: (2017)

Correction: Association of Six Well-Characterized Polymorphisms in TNF-α and TNF-β Genes with Sarcoidosis: A Meta-Analysis
por: Feng, Yun, et al.
Publicado: (2013)

Correction: Increased intratumoral mast cells foster immune suppression and gastric cancer progression through TNF-α-PD-L1 pathway
Publicado: (2020)

Correction: Serum anti-glycan-antibodies in relatives of patients with inflammatory bowel disease
por: Kamm, Florian, et al.
Publicado: (2018)

Correction: Corticosteroid Use and Complications in a US Inflammatory Bowel Disease Cohort
por: Waljee, Akbar K., et al.
Publicado: (2018)

Erratum: Transmembrane TNF-α Density, But Not Soluble TNF-α Level, is Associated with Primary Response to Infliximab in Inflammatory Bowel Disease
por: Amini Kadijani, Azade, et al.
Publicado: (2017)

Correction: Genomic and Clinical Effects Associated with a Relaxation Response Mind-Body Intervention in Patients with Irritable Bowel Syndrome and Inflammatory Bowel Disease
por: Kuo, Braden, et al.
Publicado: (2017)

Correction: ApoE deficiency promotes colon inflammation and enhances the inflammatory potential of oxidized-LDL and TNF-α in primary colon epithelial cells
por: El-Bahrawy, Ali H., et al.
Publicado: (2016)

Correction: How Serotonin Level Fluctuation Affects the Effectiveness of Treatment in Irritable Bowel Syndrome
por: Vahora, Ilmaben S, et al.
Publicado: (2020)

Correction to: Association Between Inflammatory Bowel Disease and Dementia: A Longitudinal Cohort Study
Publicado: (2022)

Correction to “Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: Current perspectives”
por: Roy, Supriya, et al.
Publicado: (2023)

A guide to preparation of patients with inflammatory bowel diseases for anti-TNF-α therapy
por: Chebli, Júlio Maria Fonseca, et al.
Publicado: (2014)

IgA Nephropathy in the Setting of Anti-TNF-α Therapy for Inflammatory Bowel Disease
por: Strobel, Thomas, et al.
Publicado: (2020)

Correction: Allele-specific DNA methylation of disease susceptibility genes in Japanese patients with inflammatory bowel disease
por: Chiba, Hirofumi, et al.
Publicado: (2019)

Anti-TNF Withdrawal in Inflammatory Bowel Disease
por: Torres, Joana, et al.
Publicado: (2016)

Correction: Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease
por: Williams, Amanda D., et al.
Publicado: (2017)

Correction: Effects of immune suppression for transplantation on inflammatory colorectal cancer progression
por: Angriman, Imerio, et al.
Publicado: (2018)

Correction: Trends in emergency department visits and hospitalization rates for inflammatory bowel disease in the era of biologics
por: Huh, Gunn, et al.
Publicado: (2019)

Correction: Decoding the language of microbiomes using word-embedding techniques, and applications in inflammatory bowel disease
por: Tataru, Christine A., et al.
Publicado: (2020)

Correction to: Abdominal hernia mesh repair in patients with inflammatory bowel disease: A systematic review
por: El Boghdady, Michael, et al.
Publicado: (2022)

Correction to: Blockade of innate inflammatory cytokines TNFα, IL-1β, or IL-6 overcomes virotherapy-induced cancer equilibrium to promote tumor regression
Publicado: (2023)

Correction: Involvement of TNF-α Converting Enzyme in the Development of Psoriasis-Like Lesions in a Mouse Model
por: Sato, Kenji, et al.
Publicado: (2015)

Author Correction: TNFα increases tyrosine hydroxylase expression in human monocytes
por: Gopinath, Adithya, et al.
Publicado: (2021)

How could nanobiotechnology improve treatment outcomes of anti-TNF-α therapy in inflammatory bowel disease? Current knowledge, future directions
por: Eder, Piotr, et al.
Publicado: (2021)

Correction to: Presenting symptoms in inflammatory bowel disease: descriptive analysis of a community-based inception cohort
por: Perler, Bryce K., et al.
Publicado: (2020)

Polymorphisms in PRKCDBP, a Transcriptional Target of TNF-α, Are Associated With Inflammatory Bowel Disease in Korean
por: Kim, Jung-Wook, et al.
Publicado: (2015)

Vedolizumab use after failure of TNF-α antagonists in children and adolescents with inflammatory bowel disease
por: Schneider, Anna-Maria, et al.
Publicado: (2018)

Inflammatory Bowel Disease as a Paradoxical Reaction to Anti-TNF-α Treatment—A Review
por: Mihai, Ioana Ruxandra, et al.
Publicado: (2023)

Correction to: Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the COVID-19 Era
por: Schreiber, Stefan, et al.
Publicado: (2022)

Correction: Incidence and prevalence of inflammatory bowel disease in UK primary care: a population-based cohort study
Publicado: (2020)

Correction to: The burden and management of anemia in Greek patients with inflammatory bowel disease: a retrospective, multicenter, observational study
por: Foteinogiannopoulou, Kalliopi, et al.
Publicado: (2021)

Correction to: Unlocking the Value of Anti-TNF Biosimilars: Reducing Disease Burden and Improving Outcomes in Chronic Immune-Mediated Inflammatory Diseases: A Narrative Review
por: Rezk, Mourad F., et al.
Publicado: (2020)

Correction: Adenosine Prevents TNFα-Induced Decrease in Endothelial Mitochondrial Mass via Activation of eNOS-PGC-1α Regulatory Axis
Publicado: (2014)

Radioimmune Imaging of α(4)β(7) Integrin and TNFα for Diagnostic and Therapeutic Applications in Inflammatory Bowel Disease
por: Signore, Alberto, et al.
Publicado: (2023)

TNFα blockade prevents the development of inflammatory bowel disease in HLA-B27 transgenic rats
por: Milia, Anna Franca, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_vr6pq83o7999qjub46d47ih2id